Report Highlights
The global microbiological technology, equipment and consumables market should reach $8.5 billion by 2027 from $5.6 billion in 2022 at a compound annual growth rate (CAGR) of 8.9% for the forecast period of 2022 to 2027.
Report Includes
- 27 tables
- An up-to-date review and analysis of the global markets for microbiology-based equipment and consumables
- Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of key market potential for microbiology consumables and equipment, technological trends, opportunities, and gaps estimating the current and future demand for microbial technologies market and its sub-segments
- Estimation of the actual market size and revenue forecast for global microbiology market in USD million values, and corresponding market share analysis based on technology type, application, end user and region
- Coverage of the technological, economic, and business considerations of global microbiology market, with analyses and growth forecasts through 2027
- Discussion of market dynamics that impact the growth of the market for microbiology consumables and equipment, clinical applications, market regulations, industry structure, and penetration of technologies within the biotech industry
- Competitive landscape of the key manufacturers and suppliers of the microbiology market, their product portfolios, financial updates, and major growth strategies within the marketplace
- Descriptive company profiles of leading industry players, including Abbott, BD, Bio-Rad Laboratories Inc., Johnson & Johnson, Sanofi SA and Thermo Fisher Scientific Inc.
Report Scope
Suppliers of microbiology consumables and equipment are discussed in terms of market share, product types, and geography. Specific consumables and equipment are almost universal to the microbiology market, but many tools are sector-specific, and this report will highlight the differences.
This report will not focus on antimicrobial compounds, either for pharmaceutical or sterilization purposes, but will focus on microbial detection methods when applicable. It will not provide a particular focus on the intersection of pharmaceuticals and microbiology, as this is beyond its scope.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||
| Forecast period considered | 2022 to 2027 | ||||||||||||||||||||||
| Base year market size | $5.1 billion | ||||||||||||||||||||||
| Market size forecast | $8.5 billion | ||||||||||||||||||||||
| Growth rate | CAGR of 8.9% for the forecast period of 2022-2027 | ||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||
| Segments covered | Reagents and other consumables, Media, and Consumable vessels | ||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (ROW) | ||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for microbiology technology, equipment and consumables market reached $9.8 billion revenue in 2015. The market should reach nearly $12.3 billion by 2020, increasing at a compound annual growth rate (CAGR) of 4.6% from 2015 to 2020.
Report Includes
- An overview of the global microbiology market.
- Analyses of global market trends, with data from 2013, 2014, 2015, and projections of CAGRs through 2020.
- Discussion of the current state, setbacks, innovations, and the future needs of the market.
- A look at the impact this market is having on other industries such as food safety, environmental, and pharmaceutical industries.
- Detailed analysis pertaining to the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
- Information regarding key manufacturers and users.
- Profiles of major suppliers of microbiology consumables and equipment.
Report Highlights
The consumables, equipment and technology markets in the microbiology industry totaled nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.
Report Includes
- An overview of the global microbiology market.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs through 2018.
- Discussion of the current state, setbacks, innovations, and the future needs of the market.
- Information regarding key manufacturers and users.
Related Reports
Global Markets and Technologies for Cell and Tissue Analysis
The global cell and tissue analysis market should reach $28.9 billion by 2027 from $18.2 billion in 2022 at a compound annual growth rate (CAGR) of 9.6% for the forecast period of 2022 to 2027.
Global Markets and Technologies for Food Safety Testing
The global food safety testing market should reach $27.1 billion by 2026 from $18.9 billion in 2021 at a compound annual growth rate (CAGR) of 7.5% for the forecast period of 2021 to 2026.
Environmental Markets for Biotechnology
U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.
Recent Reports
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
RNAi Technologies and Global Markets
The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.
Metabolomics: Technologies and Global Markets
The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.
Global Recombinant Proteins Market
The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More